The success of dietary protein restriction in alkaptonuria patients is age-dependent

Journal of Inherited Metabolic Disease

Volumn 21, Issue 8, 1998, Pages 791-798

  De Haas, V ^a   Carbasius Weber, E C ^a   De Klerk, J B C ^b   Bakker, H D ^c   Smit, G P A ^d   Huijbers, W A R ^e   Duran, M ^a   Poll The, B T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e Beatrix Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOGENTISIC ACID;

ADOLESCENT; ADULT; AGE; ALKAPTONURIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH CURVE; HUMAN; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PROTEIN RESTRICTION; SOCIAL BEHAVIOR; URINARY EXCRETION;

ADOLESCENT; ADULT; AGING; ALKAPTONURIA; BEHAVIOR; CHILD; CHILD, PRESCHOOL; DIET, PROTEIN-RESTRICTED; FEMALE; HOMOGENTISIC ACID; HUMANS; MALE; PATIENT COMPLIANCE; PIGMENTATION DISORDERS; SOCIAL BEHAVIOR;

EID: 0031738943     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005410416482     Document Type: Article

References (11)

1. Bosacco SJ, Fye M, Finn CA (1991) Alkaptonuria and ochronosis. Orthopedics 14: 394-396.
2. Duran M, Ketting D, Bruinvis L, Dorland L, Wadman SK, Bakkeren JAJM (1987) Urinary excretion of 2-methyl-2,3-butanediol and 2,3-pentanediol in patients with disorders of propionate and methylmalonate metabolism. Clin Chim Acta 165: 197-204.
3. Gaines JJ (1989) The pathology of alkaptonuric ochronosis. Hum Pathol 20: 40-46.
4. Konttinen YT, Hoikka V, Landtman M, et al (1989) Ochronosis: a report of a case and a review of literature. Clin Exp Rheumatol 7: 435-444.
5. La Du BN, Zonnoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alkaptonuria. J Biol Chem 230: 251.
6. Lustberg TJ, Schulman SD, Seegmiller JE (1970) Decreased binding of 14C-homogentisic acid induced by ascorbic acid in connective tissues of rats with experimental alkaptonuria. Nature 228: 770-771.
7. Martin JP, Batkoff B (1987) Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric patients. Free Radicals Biol Med 3: 241-250.
8. Montagutelli X, Lalouette A, Coudé M, Kamoun P, Forest M, Guénet JL (1994) Aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16. Genomics 19: 9-11.
9. O'Brien WM, La Du BN, Bunim JJ (1963) Biochemical, pathologic and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy. Review of world literature (1584-1962). Am J Med 34: 813-838.
10. Sealock RR, Galdston M, Steel JM (1940) Administration of ascorbic acid to an alkaptonuria patient. Proc Soc Exp Biol Med 44: 580-583.
11. Wolff JA, Barshop B, Nyhan WL, et al (1989) Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res 26: 140-144.